
Please try another search
Aptamer Group PLC, together with its subsidiaries, provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers; and Optimer +, a platform that discovers and develops of hybrid DNA-protein molecules that combines the features of Optimer and antibodies. It serves bioprocessing and diagnostic institutes, as well as pharmaceutical scientists. The company has strategic partnership with Unilever for the development of Optimer for use in deodorant, Neuro-Bio to develop reagents for Alzheimer’s disease test, and other pharma partner and AztraZeneca for drug delivery vehicle for fibrotic liver. The company was founded in 2008 and is headquartered in York, the United Kingdom.
Name | Age | Since | Title |
---|---|---|---|
Paul Townsend | - | - | Scientific Advisory Board Member |
Andrew Mark Rapson | 43 | 2023 | CFO, Company Secretary & Director |
Timothy James Sykes | 55 | 2024 | Non-Executive Director |
Arron Craig Tolley | 47 | 2023 | CEO, Scientific Advisory Board Deputy Chair & Director |
Adam Hargreaves | 46 | 2023 | Independent Non-Executive Chairman & Scientific Advisory Board Member |
David Bunka | 46 | 2014 | Scientific Advisory Board Chair, Chief Scientific Officer & Executive Director |
Louis Allot | - | 2024 | Scientific Advisory Board Member |
Shozo Fujita | - | 2021 | Scientific Advisory Board Member |
Paloma Giangrande | - | 2024 | Scientific Advisory Board Member |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review